Physician profile
David Alan Bernstein
NPI 1821093899
$2,291.66
in general payments reported to CMS, 2019-2025
22 companies · $79.26 in 2025
The $79.26 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,180 · 2020: $121 · 2021: $335 · 2022: $226 · 2023: $161 · 2024: $189 · 2025: $79.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $857.46 | 2019 | |
| Next Science LLC | $320.95 | 2021-2025 | Blastx, Xperience, Surgx |
| Stryker Corporation | $261.86 | 2019-2025 | Variax, Prostep |
| Smith+Nephew, INC. | $202.50 | 2019-2024 | Collagenase Santyl, Regranex |
| Embody, INC. | $98.72 | 2021 | |
| Aroa Biosurgery Incorporated | $96.13 | 2022 | |
| Amniox Medical, INC. | $57.83 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $48.35 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $47.07 | 2024 | Tapestry |
| Melinta Therapeutics, LLC | $36.88 | 2019 | |
| Hikma Pharmaceuticals USA | $34.46 | 2019-2020 | |
| Nevro Corp. | $34.40 | 2023 | Senza |
| Medtronic, INC. | $30.96 | 2023 | Intellis Adaptivestim |
| Merck Sharp & Dohme LLC | $28.32 | 2019 | |
| Heron Therapeutics, INC. | $25.01 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $21.08 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $20.13 | 2019 | |
| Alfasigma USA, INC. | $16.53 | 2021 | |
| Tactile Systems Technology INC | $14.24 | 2020 | |
| Electromed, INC. | $13.13 | 2021 | |
| Paratek Pharmaceuticals, INC. | $13.11 | 2021 | |
| Paragon 28, INC. | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.